# Serum IGF-1 and IGF-1Ec in Malignancy Assessment

> **NCT07151807** · — · ACTIVE_NOT_RECRUITING · sponsor: **Çanakkale Onsekiz Mart University** · enrollment: 100 (estimated)

## Conditions studied

- Cancer
- Solid Tumor Malignancies
- IGF1R
- Solid Cancers

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07151807
- **Lead sponsor:** Çanakkale Onsekiz Mart University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-04-01
- **Primary completion:** 2025-12
- **Final completion:** 2026-12
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2025-09-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07151807

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07151807, "Serum IGF-1 and IGF-1Ec in Malignancy Assessment". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT07151807. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*